GenoA is member of the Federative Research Structure François Bonamy (SFR Santé) which federates Nantes' biology/health research laboratories. It coordinates the Nantes technology facilities, oversees the acquisition of scientific equipment and represents Nantes' scientific community in the field of biology/health in the various local and regional bodies.

GenoA is part of the France Genomiquenational research infrastructure and of the Biogenouest interregional network of technology platforms in life sciences.

GenoA core facility leans on the research teams in human genetics and genomics at the institut du thorax. One of the scientific aims of these teams is to elucidate the molecular mechanisms of cardiovascular pathologies (sudden death, arrhythmias, valvulopathies, cerebral aneurysms).

The analysis strategies used are based on high-throughput genomic screening technologies coupled with the development supported by BiRD of new dedicated bioinformatics tools, with the aim of identifying new risk markers in these pathologies.